Shuangshuang Jia

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Newly Diagnosed

Acute Lymphoblastic Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Hailong Tang, Weijing Jia, Shuangshuang Jia, Runan Dong, Shan Gao, Juan Feng, Hongjuan Dong, Hongtao Gu, Tao Zhang, Ruifeng Yuan, Xiangxiang Liu, Lu Cheng, Shuya Zhou, Guang-Xun Gao
A new chemotherapy-free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph+ acute lymphoblastic leukemia: Preliminary outcomes of a prospective study. American journal of hematology (2024)
Hailong Tang, Weijing Jia, Shuangshuang Jia, Runan Dong, Shan Gao, Juan Feng, Hongjuan Dong, Hongtao Gu, Tao Zhang, Ruifeng Yuan, Xiangxiang Liu, Lu Cheng, Shuya Zhou, Guang-Xun Gao
A new chemotherapy-free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph+ acute lymphoblastic leukemia: Preliminary outcomes of a prospective study. American journal of hematology 99 (6) (2024)
Hailong Tang, Weijing Jia, Shuangshuang Jia, Runan Dong, Shan Gao, Juan Feng, Hongjuan Dong, Hongtao Gu, Tao Zhang, Ruifeng Yuan, Xiangxiang Liu, Lu Cheng, Shuya Zhou, Guang-Xun Gao
A new chemotherapy-free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph+ acute lymphoblastic leukemia: Preliminary outcomes of a prospective study. American journal of hematology 99 (6) (2024)